{"id":"https://openalex.org/W3083769874","doi":"https://doi.org/10.1158/1538-7445.am2020-1943","title":"Abstract 1943: SHP2 inhibition as the backbone of targeted therapy combinations for the treatment of cancers driven by oncogenic mutations in the RAS pathway","display_name":"Abstract 1943: SHP2 inhibition as the backbone of targeted therapy combinations for the treatment of cancers driven by oncogenic mutations in the RAS pathway","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083769874","doi":"https://doi.org/10.1158/1538-7445.am2020-1943","mag":"3083769874"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-1943","doi":"https://doi.org/10.1158/1538-7445.am2020-1943","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-1943","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027330002","display_name":"Jacqueline A.M. Smith","orcid":"https://orcid.org/0000-0001-5028-8725","observed_orcids":["https://orcid.org/0000-0001-5028-8725"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline A. Smith","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057362852","display_name":"Mallika Singh","orcid":"https://orcid.org/0009-0003-0234-1589","observed_orcids":["https://orcid.org/0009-0003-0234-1589"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mallika Singh","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103986436","display_name":"Robert J. Nichols","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Nichols","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040036103","display_name":"Elena S. Koltun","orcid":"https://orcid.org/0009-0005-8720-9097","observed_orcids":["https://orcid.org/0009-0005-8720-9097"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena S. Koltun","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020727899","display_name":"Yu Chi Yang","orcid":"https://orcid.org/0000-0001-8318-1174","observed_orcids":["https://orcid.org/0000-0001-8318-1174"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu C. Yang","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038156337","display_name":"David P. Wildes","orcid":"https://orcid.org/0009-0009-3855-7270","observed_orcids":["https://orcid.org/0009-0009-3855-7270"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Wildes","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000809061","display_name":"Carlos E. Stahlhut","orcid":"https://orcid.org/0000-0002-8472-7156","observed_orcids":["https://orcid.org/0000-0002-8472-7156"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Stahlhut","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100370205","display_name":"Dong Hun Lee","orcid":"https://orcid.org/0000-0002-2925-3074","observed_orcids":["https://orcid.org/0000-0002-2925-3074","https://orcid.org/0009-0000-9114-4234"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dong Lee","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085646397","display_name":"Chris J. Schulze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris J. Schulze","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112578026","display_name":"Denise F. Reyes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denise Reyes","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012645194","display_name":"Abby Marquez","orcid":"https://orcid.org/0000-0001-5104-2823","observed_orcids":["https://orcid.org/0000-0001-5104-2823"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abby Marquez","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017618412","display_name":"Grace J. Lee","orcid":"https://orcid.org/0000-0002-7430-378X","observed_orcids":["https://orcid.org/0000-0002-7430-378X"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grace J. Lee","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026492211","display_name":"Shaoling Li","orcid":"https://orcid.org/0000-0002-7621-3091","observed_orcids":["https://orcid.org/0000-0002-7621-3091"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaoling Li","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059687715","display_name":"Christophe Marcireau","orcid":"https://orcid.org/0000-0002-4550-2552","observed_orcids":["https://orcid.org/0000-0002-4550-2552"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christophe Marcireau","raw_affiliation_strings":["2Sanofi, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Sanofi, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052089394","display_name":"Laurent Deb\u00fcssche","orcid":"https://orcid.org/0000-0001-8025-0584","observed_orcids":["https://orcid.org/0000-0001-8025-0584"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurent Debussche","raw_affiliation_strings":["2Sanofi, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Sanofi, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021689661","display_name":"Mark A. Goldsmith","orcid":"https://orcid.org/0000-0001-8833-6841","observed_orcids":["https://orcid.org/0000-0001-8833-6841"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Goldsmith","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102845474","display_name":"Zhengping Wang","orcid":"https://orcid.org/0000-0001-5928-3816","observed_orcids":["https://orcid.org/0000-0001-5928-3816"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhengping Wang","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022776516","display_name":"Adrian L. Gill","orcid":"https://orcid.org/0009-0003-0914-4860","observed_orcids":["https://orcid.org/0009-0003-0914-4860"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrian L. Gill","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109158285","display_name":"Steve M. Kelsey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve M. Kelsey","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA;","institution_ids":["https://openalex.org/I4210100604"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"1943","last_page":"1943"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/shp2-inhibition","display_name":"SHP2 inhibition","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ptpn11","display_name":"PTPN11","score":0.8600000143051147},{"id":"https://openalex.org/keywords/ras-signaling","display_name":"Ras signaling","score":0.8989999890327454},{"id":"https://openalex.org/keywords/combination-targeted-therapy","display_name":"combination targeted therapy","score":0.609000027179718},{"id":"https://openalex.org/keywords/osimertinib-resistance","display_name":"osimertinib resistance","score":0.8700000047683716},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.7390000224113464},{"id":"https://openalex.org/keywords/kras-g12c","display_name":"KRAS G12C","score":0.9750000238418579},{"id":"https://openalex.org/keywords/kras-g12d","display_name":"KRAS G12D","score":0.8240000009536743},{"id":"https://openalex.org/keywords/kras-g12v","display_name":"KRAS G12V","score":0.8410000205039978},{"id":"https://openalex.org/keywords/met-amplification","display_name":"MET amplification","score":0.8190000057220459},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.8519999980926514},{"id":"https://openalex.org/keywords/drug-resistance-mechanisms","display_name":"drug resistance mechanisms","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.6095187067985535},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5783398151397705},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5128509998321533},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.49744275212287903},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.48457443714141846},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.47138625383377075},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.4603552222251892},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4284771978855133},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.4250714182853699},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4206158518791199},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4170117974281311},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.38946038484573364},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.18707504868507385},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.12463074922561646},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12315875291824341},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11219599843025208},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06140276789665222},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-1943","doi":"https://doi.org/10.1158/1538-7445.am2020-1943","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-1943","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4243537055","https://openalex.org/W4362593801","https://openalex.org/W2895494778","https://openalex.org/W2991847286","https://openalex.org/W2803222616","https://openalex.org/W3177616876","https://openalex.org/W3095796858","https://openalex.org/W4210254102","https://openalex.org/W4386241165","https://openalex.org/W2754903180"],"abstract_inverted_index":{"Abstract":[0],"Direct":[1],"targeting":[2,301],"of":[3,38,50,56,69,76,86,102,112,156,171,177,218,240,251,307,323,356,360,377,448,455,468,472],"oncogenic":[4,273,387,459],"mutations":[5,388,460],"in":[6,140,143,204,214,228,248,275,344,389,461],"the":[7,36,48,87,110,121,150,154,174,194,199,276,308,347,352,390,446,453,462,469,473],"RAS":[8,88,107,277,391,463],"pathway,":[9,278],"such":[10,268],"as":[11,21,97,127,129,180,269,315,374,445],"mutant":[12,188],"EGFR,":[13],"BRAFV600E,":[14],"and":[15,142,197,208,281,305,354,483],"most":[16],"recently":[17],"KRASG12C,":[18],"has":[19,120],"emerged":[20],"a":[22,39,54,93,98,164,229,297,310,375],"beneficial":[23],"therapeutic":[24,41,372],"strategy":[25,299,311],"for":[26,160,381,452,476],"patients":[27,382],"with":[28,186,264,385],"cancers":[29,384,456],"bearing":[30,328,383],"these":[31,295,329,361],"mutations.":[32],"Mutant-selective":[33],"inhibitors":[34,65,148,289],"offer":[35],"advantage":[37],"wide":[40],"window":[42],"but":[43,339],"are":[44,290],"ultimately":[45],"limited":[46],"by":[47,182,458],"emergence":[49],"drug":[51],"resistance.":[52],"While":[53],"variety":[55],"resistance":[57,114,256],"mechanisms":[58],"have":[59,149],"been":[60],"described,":[61],"escape":[62,133],"from":[63,134],"mutant-selective":[64,116,178,266,288],"frequently":[66],"involves":[67],"activation":[68],"wild":[70],"type":[71],"signaling":[72,126,131,247],"nodes,":[73],"including":[74,279],"hyperactivation":[75],"receptor":[77],"tyrosine":[78],"kinases":[79],"(RTKs),":[80],"that":[81,95,146,232],"lead":[82],"to":[83,105,115,123,152,236,314,320],"robust":[84],"re-activation":[85],"pathway.":[89,392],"SHP2":[90,118,147,243,443],"(PTPN11)":[91],"is":[92],"phosphatase":[94],"functions":[96],"convergent":[99],"node":[100],"downstream":[101],"multiple":[103],"RTKs":[104],"regulate":[106],"activation.":[108],"In":[109,294,325],"context":[111],"adaptive":[113,130],"inhibitors,":[117,179,267],"inhibition":[119,244,444],"potential":[122,151],"suppress":[124],"oncoprotein-mediated":[125],"well":[128],"driving":[132],"therapy.":[135],"Here":[136],"we":[137,312],"show,":[138],"using":[139],"vitro":[141,249],"vivo":[144],"systems,":[145],"become":[153,234],"backbone":[155,376,447],"targeted":[157,378,449],"therapy":[158,379,450],"combinations":[159,349,380,451],"RAS-dependent":[161],"tumors.":[162,324],"RMC-4630,":[163,369],"potent,":[165],"selective,":[166],"orally":[167],"bioavailable":[168],"allosteric":[169],"inhibitor":[170],"SHP2,":[172],"enhanced":[173],"anti-tumor":[175],"activity":[176,252],"exemplified":[181],"preclinical":[183,362],"combination":[184,298],"studies":[185],"EGFR":[187],"or":[189,286,332],"KRASG12C":[190,265],"inhibitors.":[191],"RMC-4630":[192,220,331],"accelerated":[193],"time":[195],"to,":[196],"increased":[198,351],"magnitude":[200],"of,":[201],"tumor":[202,212,226,342,357],"regressions":[203,322,343],"osimertinib-sensitive":[205],"EGFR-mutant":[206],"tumors":[207],"delayed":[209],"and/or":[210],"reduced":[211],"regrowth":[213],"mice":[215],"upon":[216],"cessation":[217],"treatment.":[219],"was":[221,318],"also":[222,261],"effective":[223],"at":[224],"inhibiting":[225],"growth":[227,338],"PDX":[230],"model":[231],"had":[233],"resistant":[235],"osimertinib":[237,255],"via":[238],"amplification":[239],"c-MET.":[241],"Lastly,":[242],"blocked":[245],"EGFRL858R/T790M/C797S":[246],"indicative":[250],"against":[253],"on-target":[254],"mechanisms.":[257],"Combination":[258],"benefits":[259],"were":[260],"observed":[262],"preclinically":[263],"AMG-510.":[270],"For":[271],"other":[272],"drivers":[274],"KRASG12D":[280],"KRASG12V,":[282],"NF1LOF,":[283],"KRAS":[284],"amplifications":[285],"BRAFClass3,":[287],"not":[291],"currently":[292],"available.":[293],"contexts,":[296],"simultaneously":[300],"nodes":[302],"both":[303],"up-":[304],"down-stream":[306],"oncoprotein,":[309],"refer":[313],"\u201concoprotein":[316],"clamping,\u201d":[317],"able":[319],"drive":[321],"xenograft":[326],"models":[327],"mutations,":[330],"cobimetinib":[333],"alone":[334],"dosed":[335],"sub-MTD":[336],"inhibited":[337],"induced":[340],"few":[341],"mice.":[345],"However,":[346],"corresponding":[348],"markedly":[350],"number":[353],"depth":[355],"regressions.":[358],"Translation":[359],"findings":[363],"into":[364],"clinical":[365],"benefit":[366],"could":[367],"position":[368],"an":[370],"investigational":[371],"agent,":[373],"diverse":[386],"Citation":[393],"Format:":[394],"Jacqueline":[395],"A.":[396,433],"Smith,":[397],"Mallika":[398],"Singh,":[399],"Robert":[400],"J.":[401,417,424],"Nichols,":[402],"Elena":[403],"S.":[404],"Koltun,":[405],"Yu":[406],"C.":[407],"Yang,":[408],"David":[409],"P.":[410],"Wildes,":[411],"Carlos":[412],"Stahlhut,":[413],"Dong":[414],"Lee,":[415,425],"Chris":[416],"Schulze,":[418],"Denise":[419],"Reyes,":[420],"Abby":[421],"Marquez,":[422],"Grace":[423],"Shaoling":[426],"Li,":[427],"Christophe":[428],"Marcireau,":[429],"Laurent":[430],"Debussche,":[431],"Mark":[432],"Goldsmith,":[434],"Zhengping":[435],"Wang,":[436],"Adrian":[437],"L.":[438],"Gill,":[439],"Steve":[440],"M.":[441],"Kelsey.":[442],"treatment":[454],"driven":[457],"pathway":[464],"[abstract].":[465],"In:":[466],"Proceedings":[467],"Annual":[470],"Meeting":[471],"American":[474],"Association":[475],"Cancer":[477,489],"Research":[478],"2020;":[479],"2020":[480],"Apr":[481],"27-28":[482],"Jun":[484],"22-24.":[485],"Philadelphia":[486],"(PA):":[487],"AACR;":[488],"Res":[490],"2020;80(16":[491],"Suppl):Abstract":[492],"nr":[493],"1943.":[494]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2020-09-11T00:00:00"}